601 Results

People

  1. Devlin
    Devlin
  2. Giralt
    Giralt
  3. Perales
    Perales
  4. Shah
    Shah
  5. Dahi
    Dahi
  6. Scordo
    Scordo
  7. Jakubowski
    Jakubowski
  8. Ponce
    Ponce
  9. Papadopoulos
    Papadopoulos
  10. Sauter
    Sauter

Groups

  1. Biostatistics Service (601)
  2. Epidemiology and Biostatistics (601)
  3. Department of Medicine (574)
  4. Hematologic Malignancies, Division of (573)
  5. Center for Hematologic Malignancies (570)
  6. Bone Marrow Transplant (457)
  7. Survivorship Research (383)
  8. CTCR Scholars (321)
  9. MSK Grad Students (277)
  10. Master of Science in Clinical and Translational Cancer Research (265)
  1. "Sean Devlin"
Formats
  1. Meeting Abstract (365)
  2. Journal Article (215)
  3. Research Letter (14)
  4. Correspondence (5)
  5. Editorial (1)
  6. Review (1)
Groups
  1. Biostatistics Service (601)
  2. Epidemiology and Biostatistics (601)
  3. Department of Medicine (574)
  4. Hematologic Malignancies, Division of (573)
  5. Center for Hematologic Malignancies (570)
  6. Bone Marrow Transplant (457)

More Groups

People
  1. Sean Devlin (601)
  2. Sergio Giralt (372)
  3. Miguel-Angel Perales (293)
  4. Gunjan Shah (177)
  5. Molly Maloy (162)
  6. Parastoo Dahi (155)

More People

Years
  1. 2025 (13)
  2. 2024 (25)
  3. 2023 (52)
  4. 2022 (42)
  5. 2021 (36)
  6. 2020 (56)

More Years

Publications
  1. Blood (194)
  2. Biology of Blood and Marrow Transplantation (133)
  3. Bone Marrow Transplantation (51)
  4. Blood Advances (28)
  5. Transplantation and Cellular Therapy (25)
  6. Journal of Clinical Oncology (15)

More Publications

Publishers
  1. American Society of Hematology (222)
  2. Elsevier Inc. (175)
  3. Nature Publishing Group (73)
  4. Taylor & Francis Group (16)
  5. American Society of Clinical Oncology (15)
  6. Ferrata Storti Foundation (12)

More Publishers

Results (601)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Measuring the impact of new risk factors within survival models
    Journal Article

    Heller, G.; Devlin, S. M.
    Journal of the Royal Statistical Society Series C - Applied Statistics (2025)

    Fulltext@MSK | Save
  • Minimal residual disease as an early endpoint for accelerated drug approval in myeloma: A roadmap
    Review

    Landgren, O.; Devlin, S. M.
    Blood Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Tumor determinants of response to CAR-T therapy in relapsed or refractory mantle cell lymphoma
    Meeting Abstract

    Epstein-Peterson, Z. D.; Ryan, C. E.; Devlin, S. M.; Accav, N. G.; Avigdor, A.; Corona, M.; Danylesko, I.; Dela Cruz, J.; Goy, A.; Jacobson, C. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • GVHD therapy with ruxolitinib is frequently associated with cytopenias, but significant decline in hemoglobin level was only observed in non-responders at day 28
    Meeting Abstract

    Gergoudis, S.; Devlin, S. M.; Susman, P.; Singh, A.; Chinapen, S.; Perales, M. A.; Ponce, D. M.
    Blood (2024)

    Fulltext@MSK | Save
  • Developing an optimal fully-human CD371-targeting IL-18 secreting CART cell for the treatment of acute myeloid leukemia
    Meeting Abstract

    Shahid, S.; Mathew, S.; Souness, S.; Burns, E. R.; Um, J. S.; Yoo, S.; Cai, W.; Pohl, M. A.; Fujino, T.; Zhang, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Site-specific responses and extranodal involvement implications in large B-cell lymphomas treated with CD19-CART therapy
    Meeting Abstract

    Luna de Abia, A.; Devlin, S. M.; Flynn, J.; Corona De Lapuerta, M.; Luttwak, E.; Landego, I.; Dahi, P. B.; Lin, R. J.; Parascondola, A.; Palomba, M. L.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Improvement in radiomic features following bridging therapy is prognostic for CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H. G.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Boardman, A.; Dahi, P. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Establishing a graft-versus-host disease (GVHD)-focused multidisciplinary telehealth clinic
    Journal Article

    Harris, A. C.; Markova, A.; Devlin, S.; Singh, A.; Susman, P.; Brown, S.; Grasso, C.; Custodio, C.; Estilo, C.; Ibanez, K.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save